Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
160 participants
INTERVENTIONAL
2023-03-01
2027-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
TSA v RSA in Osteoarthritic Shoulders With Greater Than 15 Degrees of Retroversion
NCT05487274
Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma(PRP) in Large to Massive Tears
NCT01238302
Arthroscopic Rotator Cuff Repair With Synovectomy
NCT03061942
Massive Rotator Cuff Tear Reconstruction
NCT03425500
Subscapularis Repair in Reverse Shoulder Arthroplasty
NCT05438914
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Different treatment options are available for massive or irreparable rotator cuff tears, including debridement and subacromial decompression, repair (partial or complete), transfer of the subscapularis tendon, transfer of the teres major muscle, deltoid flap reconstruction, transfer of the latissimus dorsi or the pectoralis major, superior capsule reconstruction, augmented cuff repair, subacromial balloon and reverse total shoulder replacements. None of these treatments has proved superiority on other ones, particularly when the rotator cuff is massively torn.
Massive degenerative rotator ruff tears are a challenge. An arthroscopic or an open repair approach is possible in the majority of cases and functional outcomes are improved, particularly when a complete arthroscopic repair can be achieved. However, the healing rate of massive rotator cuff tears after repair may remain low and failure of healing is associated with progression of arthritis. An alternative to arthroscopic or open repair is reverse shoulder arthroplasty which decreases pain and improves function, active shoulder elevation and quality of life. Recently, Liu et al. demonstrated that both rotator cuff repair (RCR) and reverse shoulder arthroplasty (RSA) are effective and reliable options for massive rotator cuff tears (RCT), but revealed a better shoulder function for patients in the rotator cuff repair (RCR) group. While these results are interesting, this study remains retrospective and call for new studies with a higher level of evidence.
The primary goal of this prospective multicentric randomized study is to determine if there is a difference of functional outcomes between rotator cuff repair (RCR) repair and reverse shoulder arthroplasty (RSA).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arthroscopic surgery
The massive degenerative rotator cuff tear are treated by arthroscopy. It consists in reattaching the torn tendon with anchors and sutures.
Arthroscopy
The surgeon reattaches the torn tendon to the bone with anchors and sutures.
Reverse shoulder arthroplasty
The problems induced by the massive degenerative rotator cuff tear are solved by a complete replacement of the shoulder joint with a prosthesis (reverse design).
Reverse Shoulder Arthroplasty
It consists in replacing the shoulder joint with a total shoulder prosthesis (reverse design).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Arthroscopy
The surgeon reattaches the torn tendon to the bone with anchors and sutures.
Reverse Shoulder Arthroplasty
It consists in replacing the shoulder joint with a total shoulder prosthesis (reverse design).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2 Patient with a massive and reparable non traumatic rotator cuff tears after failure of conservative treatment
* 3 Patients with the following pre-operative images: Three standardized X-rays series and Magnetic Resonance Imaging (MRI) or arthro Magnetic Resonance Imaging without sign of traumatic lesions
Exclusion Criteria
* 2 Revision rotator cuff repair
* 3 Patient consent withdrawal
* 4 Glenohumeral arthritis defined as stage \> 3 Hamada classification
* 5 Infection and neuropathic joints
* 6 Known or suspected non-compliance, drug or alcohol abuse
* 7 Patients incapable of judgement or under tutelage
* 8 Inability to follow the procedures of the study
* 9 Enrolment of the investigator, his/her family members, employees and other dependent persons
60 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
La Tour Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Alexandre Lädermann
Orthopaedic Surgeon FMH, Shoulder and Elbow Surgery Traumatology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexandre Lädermann, MD
Role: PRINCIPAL_INVESTIGATOR
La Tour hospital, Meyrin (1217) Geneva, Switzerland
Patrick Denard, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Orthopaedics and Rehabilitation, Oregon Health & Science University, Portland, OR, USA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oregon Health & Science University
Portland, Oregon, United States
La Tour hospital
Meyrin, Canton of Geneva, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Patrick Denard, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Ladermann A, Pernoud A, Cochard B, Bothorel H. Treatment of degenerative massive rotator cuff tears: a study protocol for a randomized non-inferiority comparative surgical trial. Trials. 2025 Aug 4;26(1):270. doi: 10.1186/s13063-025-08990-9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-00111
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.